The Ethics and Governance of an Emerging Technology in an Emerging Market: The Case of Private Umbilical Cord Blood Banking in India

  • Shashank S. Tiwari
Part of the Advances in Theory and Practice of Emerging Markets book series (ATPEM)


This chapter discusses the proliferation of private cord blood banking in India. It explores (a) the pattern of commercialisation, (b) the hope rhetoric, (c) the ethical and social issues raised and (d) the governance of cord blood banking and the problems facing the existing system of oversight. The study shows that hope and hype associated with an emerging technology in an emerging market such as India raise significant social, ethical and governance issues and concerns. Finally, the chapter argued that “hype bubbles” can damage both the market and the technological innovation in the absence of effective regulations.


Emerging market Emerging technology Private cord blood banking India 



The chapter is the part of a Wellcome Trust Studentship (grant number: WT087867MA) awarded to Shashank Tiwari at the Institute for Science and Society, School of Sociology and Social Policy, University of Nottingham, Nottingham (UK). The Trust is not responsible for views expressed in this letter. The author is grateful to Paul Martin, Sujatha Raman and Pranav Desai for support and guidance.


  1. Agarwal, M. (2006). Umbilical cord blood transplantation: Newer trends. JAPI, 54, 143–147.Google Scholar
  2. Bedi, A. (2017, July 24). Cord blood firms turn Astrologers. Outlook.Google Scholar
  3. Bharadwaj, A., & Glasner, P. (2009). Local cells, global science: The proliferation of stem cell technologies in India. New York, NY: Routledge.Google Scholar
  4. Borrás, S., & Edquist, C. (2014). Institutions and regulations in innovation systems: Effects, problems and innovation policy design. Retrieved from. Scholar
  5. Borup, M., Brown, N., Konrad, K., & Van Lente, H. (2006). The sociology of expectations in science and technology. Technology Analysis & Strategic Management, 18(3–4), 285–298.Google Scholar
  6. Brown, N., & Kraft, A. (2006). Blood ties: Banking the stem cell promise. Technology Analysis & Strategic Management, 18(3–4), 313–327.Google Scholar
  7. Brown, N., & Michael, M. (2003). A sociology of expectations: Retrospecting prospects and prospecting retrospects. Technology Analysis & Strategic Management, 15(1), 3–18.Google Scholar
  8. Gottweis, H., Salter, B., & Waldby, C. (2009). The global politics of human embryonic stem cell science: Regenerative medicine in transition. In Basingstoke. New York, NY: Palgrave Macmillan.Google Scholar
  9. Heinz, D. B., & Tomenendal, M. (2012). The emerging market hype–putting market size and growth in BRIC countries into perspective. Critical Perspectives on International Business, 8(3), 241–258.Google Scholar
  10. Hoskisson, R. E., Wright, M., Filatotchev, I., & Peng, M. W. (2013). Emerging multinationals from mid-range economies: The influence of institutions and factor markets. Journal of Management Studies, 50(7), 1295–1321.Google Scholar
  11. Kaimal, A. J., Smith, C. C., Laros, R. K., Jr., Caughey, A. B., & Cheng, Y. W. (2009). Cost-effectiveness of private umbilical cord blood banking. Obstetrics & Gynecology, 114(4), 848–855.Google Scholar
  12. Kant, A. (2015). Transforming India into a global manufacturing hub. Yojna, 59(March), 18–22.Google Scholar
  13. LifeCell launches community stem cell bank. (2017, March 10). The Hindu Business Line.Google Scholar
  14. Martin, P., Brown, N., & Turner, A. (2008). Capitalizing hope: The commercial development of umbilical cord blood stem cell banking. New Genetics and Society, 27(2), 127–143.Google Scholar
  15. Mascarenhas, A. (2009, October 2). Biological insurance: Cord blood banking on the rise in city. The Indian Express.Google Scholar
  16. Nelson, B. (2008, March 13). Stem-cell banking: life line or sub-prime? Nature Reports Stem Cells Google Scholar
  17. Patra, P. K., & Sleeboom-Faulkner, M. (2016). Following the banking cycle of umbilical cord blood in India: The disparity between pre-banking persuasion and post-banking utilization. New Genetics and Society, 35(3), 267–288.Google Scholar
  18. Petersen, A. (2009). The ethics of expectations. Monash Bioethics Review, 28(1), 22–33.Google Scholar
  19. Petersen, A. (2011). The politics of bioethics. New York, NY: Routledge.Google Scholar
  20. Puigdomench-Rosell, P., & Virt, G. (2004). Ethical aspects of umbilical cord blood banking. European Group on Ethics in Science and New Technologies, European Commission.Google Scholar
  21. Rajan, K. S. (2006). Biocapital: The constitution of postgenomic life. Durham, CA: Duke University Press.Google Scholar
  22. Sharma, A. (2009). Stem cell research and policy in India: Current scenario and future perspective. Journal of Stem Cells, 4(2), 133–140.Google Scholar
  23. Sipp, D. (2011). Global challenges in stem cell research and the many roads ahead. Neuron, 70(4), 573–576.Google Scholar
  24. Srinivasan, S. (2010, August 18). The Wilde West of stem cell procedures. Infochange.Google Scholar
  25. Sullivan, M., Browett, P., & Patton, N. (2005). Private umbilical cord blood banking: A biological insurance of dubious future benefit! The New Zealand Medical Journal (Online), 118(1208), 1–6.Google Scholar
  26. Tiwari, S. S. (2014, November 5). Cord blood banking: Ambiguous policy. Deccan Herold.Google Scholar
  27. Tiwari, S. S. (2015, June 9). Proliferation of stem cell therapies: Regulatory challenges. Pharmabiz. Google Scholar
  28. Tiwari, S. S., & Desai, P. N. (2011). Stem cell innovation system in India: Emerging scenario and future challenges. World Journal of Science Technology and Sustainable Development, 8(1), 1–23.Google Scholar
  29. Tiwari, S. S., & Raman, S. (2014). Governing stem cell therapy in India: Regulatory vacuum or jurisdictional ambiguity? New Genetics and Society, 33(4), 413–433.Google Scholar
  30. Tiwari, S. S., & Tiwary, E. (2015). India: Assess social impact of technology. Nature, 522(7557), 419–419.Google Scholar
  31. Tracey, P., & Phillips, N. (2011). Entrepreneurship in emerging markets. Management International Review, 51(1), 23–39.Google Scholar
  32. World $15.63 Billion Stem Cells Market Analysis 2014–2025. (2017, July 13). WBRC.Google Scholar

Copyright information

© Springer International Publishing AG, part of Springer Nature 2018

Authors and Affiliations

  1. 1.Institute for Science and Society (ISS), School of Sociology and Social Policy, University of NottinghamNottinghamUK

Personalised recommendations